丙型肝炎,基因型 1的临床试验
总计2367个结果
-
Bader, Ted, M.D.完全的
-
National Taiwan University HospitalNational Science Council, Taiwan; Department of Health, Executive Yuan, R.O.C. (Taiwan)完全的
-
Romark Laboratories L.C.完全的
-
AbbVie完全的
-
HaEmek Medical Center, IsraelAbbVie完全的
-
University of North Carolina, Chapel HillNational Institutes of Health (NIH); National Center for Complementary and Integrative Health...完全的
-
Vertex Pharmaceuticals Incorporated完全的
-
Gilead Sciences终止慢性丙型肝炎美国, 澳大利亚, 加拿大, 新西兰
-
National Taiwan University HospitalNational Science Council, Taiwan未知
-
Merck Sharp & Dohme LLC撤销
-
Seoul National University Boramae HospitalRoche Pharma AG完全的
-
Bausch Health Americas, Inc.完全的
-
ANRS, Emerging Infectious DiseasesInstitut Pasteur未知
-
Dynavax Technologies CorporationPPD; Synteract, Inc.完全的
-
Merck Sharp & Dohme LLC完全的
-
Alios Biopharma Inc.Vertex Pharmaceuticals Incorporated完全的
-
Kaohsiung Medical University Chung-Ho Memorial...完全的
-
Bristol-Myers Squibb不再可用
-
Janssen R&D Ireland完全的
-
National Opinion Research CenterUniversity of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai; Centers for Disease... 和其他合作者完全的